🔗 Permalink

Inventor profile of:

Gregor Schulz

City:

Umkirch

Country:

Germany

Published Applications:

Last publication date:

2019-04-25

Top Assignees for applications by Gregor Schulz

The entities that hold a legal rights for patent applications filed by inventor Schulz Gregor:

BIOTEST AG 9 Dreieich, Germany
ImmunoGen, INC. 5 Waltham, MA United States
BIOTEST AG 1 , Germany

Recent patent applications by Schulz Gregor

Gregor Schulz from Umkirch, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-04-25

US20190117770A1

Human necessities

USES OF IMMUNOCONJUGATES TARGETING CD138

#2 | 2017-03-23

US20170081418A1

Chemistry; metallurgy

IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF

#3 | 2016-06-30

US20160185854A1

Chemistry; metallurgy

AGENTS TARGETING CD138 AND USES THEREOF

#4 | 2014-01-09

US20140010828A1

Human necessities

Uses of immunoconjugates targeting CD138

#5 | 2013-01-03

US20130004513A1

Physics

Agents for treating disease

#6 | 2011-09-22

US20110229465A1

Chemistry; metallurgy

COMPOSITION FOR TREATING DISEASE

#7 | 2011-05-26

US20110123554A1

Human necessities

Uses of immunoconjugates targeting CD138

#8 | 2011-03-10

US20110059083A1

Chemistry; metallurgy

Method for treating psoriasis

#9 | 2011-03-10

US20110059082A1

Chemistry; metallurgy

Agent for treating disease

#10 | 2009-09-17

US20090232810A1

Chemistry; metallurgy

Immunoconjugates targeting CD138 and uses thereof

#11 | 2009-07-16

US20090181038A1

Chemistry; metallurgy

Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates

#12 | 2009-07-09

US20090175863A1

Chemistry; metallurgy

Agents targeting CD138 and uses thereof

InventorID:

10686 ⎘